ClinicalTrials.govpublic full text
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
alzheimer disease, dementia, alzheimer type, e2609, mild cognitive impairment, mild to moderate dementia, alzheimer's disease, prodromal alzheimer's disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 826477
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.